Brief Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastrointest Pharmacol Ther. Oct 6, 2012; 3(5): 74-82
Published online Oct 6, 2012. doi: 10.4292/wjgpt.v3.i5.74
Table 2 Characteristics of study participants
CharacteristicsData (%)
GenderFemale: 19/46 (41.3)
Male: 27/46 (58.7)
RaceAfrican American: 5/46 (10.9)
Caucasian: 41/46 (89.1)
Age, yrMean: 42.6
Median: 41.5
Range: 21-89
Disease typeUlcerative colitis: 9/46 (19.6)
Crohn's: 37/46 (80.4)
Use of premedications17/46 (37.0)
On corticosteroid therapy1/46 (2.2)
On immunosuppressive therapy10/46 (21.7)
Dose5 mg/kg: 25/46 (54.3)
7.5 mg/kg: 5/46 (10.9)
10 mg/kg: 16/46 (34.8)
Number of infusions prior to accelerated protocolMean: 27.4
Median: 22
Range: 4-65
Body mass indexNormal (18.5-25.0): 19/46 (41.3)
Low (< 18.5): 1/46 (2.2)
High (> 25.0): 26/46 (56.5)